GlassScriptPhysician profile
James D Green
NPI 1265438493
$10,083.85
in general payments reported to CMS, 2019-2025
13 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,330 · 2020: $67.36 · 2021: $115 · 2023: $221 · 2024: $5,881 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,280 · Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,280.20 |
| Food and Beverage | $1,290.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oticon Medical, LLC | $5,529.85 | 2024 | Ponto Bone Anchored Hearing System |
| Medtronic USA, INC. | $2,887.50 | 2019 | |
| Cochlear Americas | $553.62 | 2019-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Med-El Corporation | $295.33 | 2019-2023 | Mi1250 Synchrony 2 Flexsoft |
| Integra Lifesciences Corporation | $162.30 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Smith+Nephew, INC. | $145.14 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $121.12 | 2025 | Dupixent |
| Genzyme Corporation | $115.13 | 2021 | |
| Stryker Corporation | $95.34 | 2024 | Xpress Loprofile |
| Glaxosmithkline, LLC. | $93.24 | 2024 | Nucala |
| Medtronic, INC. | $50.53 | 2023 | Fusion |
| Otsuka America Pharmaceutical, INC. | $17.91 | 2023 | Rexulti |
| Novartis Pharmaceuticals Corporation | $16.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.